188 related articles for article (PubMed ID: 35349635)
1. Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
Lee TH; Hunt CM; Maier MM; Lowy E; Beste LA
Clin Infect Dis; 2022 Oct; 75(9):1529-1536. PubMed ID: 35349635
[TBL] [Abstract][Full Text] [Related]
2. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
[TBL] [Abstract][Full Text] [Related]
3. Care quality and outcomes among US veterans with chronic hepatitis B in the hepatitis C direct-acting antiviral era.
Kaplan DE; Medvedeva E; Serper M
J Viral Hepat; 2020 Oct; 27(10):1082-1092. PubMed ID: 32484991
[TBL] [Abstract][Full Text] [Related]
4. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
[TBL] [Abstract][Full Text] [Related]
5. Triple Threat: HDV, HBV, HIV Coinfection.
Yen DW; Soriano V; Barreiro P; Sherman KE
Clin Liver Dis; 2023 Nov; 27(4):955-972. PubMed ID: 37778779
[TBL] [Abstract][Full Text] [Related]
6. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.
Surial B; Ramírez Mena A; Roumet M; Limacher A; Smit C; Leleux O; Mocroft A; van der Valk M; Bonnet F; Peters L; Rockstroh JK; Günthard HF; Berzigotti A; Rauch A; Wandeler G; ; ; ;
J Hepatol; 2023 May; 78(5):947-957. PubMed ID: 36690280
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
[TBL] [Abstract][Full Text] [Related]
8. Utilization of Antiviral Therapy for Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Nationwide Real-World US Study.
Kudaravalli S; Kam LY; Huang DQ; Cheung R; Nguyen MH
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3305-3313.e4. PubMed ID: 37805836
[TBL] [Abstract][Full Text] [Related]
9. Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study.
Riebensahm C; Chitundu H; Muula G; Chihota B; Sinkala E; Sunkutu V; Maurer MH; Dufour JF; Berzigotti A; Egger M; Bolton-Moore C; Vinikoor M; Wandeler G;
Int J Infect Dis; 2022 Mar; 116():391-396. PubMed ID: 34952210
[TBL] [Abstract][Full Text] [Related]
10. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
[TBL] [Abstract][Full Text] [Related]
11. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis.
Surial B; Wyser D; Béguelin C; Ramírez-Mena A; Rauch A; Wandeler G
Liver Int; 2021 Apr; 41(4):710-719. PubMed ID: 33220137
[TBL] [Abstract][Full Text] [Related]
13. Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis B.
Patel N; Post FA
Int J STD AIDS; 2022 Feb; 33(2):202-204. PubMed ID: 34546112
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.
Ferrante ND; Lo Re V
Curr HIV/AIDS Rep; 2020 Aug; 17(4):405-414. PubMed ID: 32607773
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
[TBL] [Abstract][Full Text] [Related]
16. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
[TBL] [Abstract][Full Text] [Related]
17. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia.
Muula GK; Bosomprah S; Sinkala E; Nsokolo B; Musonda T; Hamusonde K; Bhattacharya D; Lauer G; Chung RT; Mulenga LB; Wandeler G; Vinikoor MJ
AIDS; 2023 Nov; 37(13):2015-2020. PubMed ID: 37467044
[TBL] [Abstract][Full Text] [Related]
19. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort.
Dezanet LNC; Kassime R; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A
Clin Infect Dis; 2022 Mar; 74(6):1012-1021. PubMed ID: 34197574
[TBL] [Abstract][Full Text] [Related]
20. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain.
Ramos-Rincon JM; Pinargote-Celorio H; de Mendoza C; Ramos-Belinchón C; Barreiro P; Treviño A; Corral O; Soriano V
Aliment Pharmacol Ther; 2023 Mar; 57(5):540-548. PubMed ID: 36320189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
